● Investor

Regeneron Pharmaceuticals

Regeneron Ventures, founded in 2024, is the corporate venture capital arm of Regeneron Pharmaceuticals, focusing on investments in the biopharmaceutical, healthcare, devices, tools, and health technology sectors. The firm is actively seeking new investments and has a portfolio of 12 companies, leveraging Regeneron's expertise in biotechnology to drive innovation in healthcare.

Corporate VCGreenwich, United States

Portfolio

1

companies tracked

Rounds · 12mo

0

participated in

Est. deployed · 12moEstimated by summing amounts of tracked rounds. Actual check sizes vary and often aren't disclosed.

—

sum of tracked rounds

Top stage

—

by round count

Recent activity

Rounds LatestRounds has tracked from this investor.

TruvetaBellevue
Series C$320MJan 13
TruvetaBellevue
Series B$320MOct 5
TruvetaBellevue
Series A$95MApr 28